Literature DB >> 18032492

Induction of heterosubtypic immunity to influenza virus by intranasal immunization.

Fu-Shi Quan1, Richard W Compans, Huan H Nguyen, Sang-Moo Kang.   

Abstract

Recovery from live influenza virus infection is known to induce heterosubtypic immunity. In contrast, immunity induced by inactivated vaccines is predominantly subtype specific. In this study, we investigated the heterosubtypic protective immunity induced by inactivated influenza virus. Intranasal immunization of mice with inactivated influenza virus A/PR8 (H1N1) provided complete protection against the homologous virus and a drift virus within the same subtype, A/WSN (H1N1), but not against the heterosubtypic virus A/Philippines (H3N2). However, coadministration of inactivated virus with cholera toxin as an adjuvant conferred complete heterosubtypic protection, without observed illness, even under conditions of CD4(+) or CD8(+) T-cell depletion. Analysis of immune correlates prior to challenge and postchallenge indicated that humoral immune responses with cross-neutralizing activity in lungs and in sera play a major role in conferring protective immunity against heterosubtypic challenge. This study has significant implications for developing broadly cross-reactive vaccines against newly emerging pathogenic influenza viruses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18032492      PMCID: PMC2224423          DOI: 10.1128/JVI.01615-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Ginseng and Salviae herbs play a role as immune activators and modulate immune responses during influenza virus infection.

Authors:  Fu Shi Quan; Richard W Compans; Young-Keol Cho; Sang-Moo Kang
Journal:  Vaccine       Date:  2006-08-10       Impact factor: 3.641

Review 2.  Mucosal adjuvants.

Authors:  L C Freytag; J D Clements
Journal:  Vaccine       Date:  2005-03-07       Impact factor: 3.641

3.  Priming with cold-adapted influenza A does not prevent infection but elicits long-lived protection against supralethal challenge with heterosubtypic virus.

Authors:  Timothy J Powell; Tara Strutt; Joyce Reome; Joseph A Hollenbaugh; Alan D Roberts; David L Woodland; Susan L Swain; Richard W Dutton
Journal:  J Immunol       Date:  2007-01-15       Impact factor: 5.422

4.  Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus.

Authors:  Fu-Shi Quan; Chunzi Huang; Richard W Compans; Sang-Moo Kang
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

5.  Humoral immunity due to long-lived plasma cells.

Authors:  M K Slifka; R Antia; J K Whitmire; R Ahmed
Journal:  Immunity       Date:  1998-03       Impact factor: 31.745

6.  Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell-depleted, beta2-microglobulin-deficient, and J chain-deficient mice.

Authors:  S L Epstein; C Y Lo; J A Misplon; C M Lawson; B A Hendrickson; E E Max; K Subbarao
Journal:  J Immunol       Date:  1997-02-01       Impact factor: 5.422

7.  Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls.

Authors:  Ron A M Fouchier; Vincent Munster; Anders Wallensten; Theo M Bestebroer; Sander Herfst; Derek Smith; Guus F Rimmelzwaan; Björn Olsen; Albert D M E Osterhaus
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

8.  Protection against a lethal avian influenza A virus in a mammalian system.

Authors:  J M Riberdy; K J Flynn; J Stech; R G Webster; J D Altman; P C Doherty
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

9.  Heterosubtypic immunity to lethal influenza A virus infection is associated with virus-specific CD8(+) cytotoxic T lymphocyte responses induced in mucosa-associated tissues.

Authors:  H H Nguyen; Z Moldoveanu; M J Novak; F W van Ginkel; E Ban; H Kiyono; J R McGhee; J Mestecky
Journal:  Virology       Date:  1999-02-01       Impact factor: 3.616

10.  Intranasal immunization with influenza virus and Korean mistletoe lectin C (KML-C) induces heterosubtypic immunity in mice.

Authors:  Seong Kyu Song; Zina Moldoveanu; Huan H Nguyen; Eui Ho Kim; Kwan Yong Choi; Jong Bae Kim; Jiri Mestecky
Journal:  Vaccine       Date:  2007-07-02       Impact factor: 3.641

View more
  91 in total

1.  Biopolymer encapsulated live influenza virus as a universal CD8+ T cell vaccine against influenza virus.

Authors:  Alina C Boesteanu; Nadarajan S Babu; Margaret Wheatley; Elisabeth S Papazoglou; Peter D Katsikis
Journal:  Vaccine       Date:  2010-10-27       Impact factor: 3.641

2.  Microneedle patch delivery to the skin of virus-like particles containing heterologous M2e extracellular domains of influenza virus induces broad heterosubtypic cross-protection.

Authors:  Min-Chul Kim; Jeong Woo Lee; Hyo-Jick Choi; Yu-Na Lee; Hye Suk Hwang; Jongsang Lee; Cheol Kim; Jong Seok Lee; Carlo Montemagno; Mark R Prausnitz; Sang-Moo Kang
Journal:  J Control Release       Date:  2015-05-21       Impact factor: 9.776

3.  Fc receptor is not required for inducing antibodies but plays a critical role in conferring protection after influenza M2 vaccination.

Authors:  Yu-Na Lee; Young-Tae Lee; Min-Chul Kim; Hye Suk Hwang; Jong Seok Lee; Ki-Hye Kim; Sang-Moo Kang
Journal:  Immunology       Date:  2014-10       Impact factor: 7.397

4.  Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles.

Authors:  Yeu-Chun Kim; Fu-Shi Quan; Dae-Goon Yoo; Richard W Compans; Sang-Moo Kang; Mark R Prausnitz
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

5.  Virus-like particles containing multiple M2 extracellular domains confer improved cross-protection against various subtypes of influenza virus.

Authors:  Min-Chul Kim; Jae-Min Song; Eunju O; Young-Man Kwon; Youn-Jeong Lee; Richard W Compans; Sang-Moo Kang
Journal:  Mol Ther       Date:  2012-12-18       Impact factor: 11.454

6.  Kinetics of immune responses to influenza virus-like particles and dose-dependence of protection with a single vaccination.

Authors:  Fu Shi Quan; Dae-Goon Yoo; Jae-Min Song; John D Clements; Richard W Compans; Sang-Moo Kang
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

7.  Prior infection with classical swine H1N1 influenza viruses is associated with protective immunity to the 2009 pandemic H1N1 virus.

Authors:  John C Kash; Li Qi; Vivien G Dugan; Brett W Jagger; Rachel J Hrabal; Matthew J Memoli; David M Morens; Jeffery K Taubenberger
Journal:  Influenza Other Respir Viruses       Date:  2010-05-01       Impact factor: 4.380

8.  Virus-like particle vaccine protects against 2009 H1N1 pandemic influenza virus in mice.

Authors:  Fu-Shi Quan; Aswani Vunnava; Richard W Compans; Sang-Moo Kang
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

9.  Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin.

Authors:  Fu-Shi Quan; Yeu-Chun Kim; Dae-Goon Yoo; Richard W Compans; Mark R Prausnitz; Sang-Moo Kang
Journal:  PLoS One       Date:  2009-09-25       Impact factor: 3.240

10.  Case-based surveillance of influenza hospitalizations during 2004-2008, Colorado, USA.

Authors:  Rosemary Proff; Ken Gershman; Dennis Lezotte; Ann-Christine Nyquist
Journal:  Emerg Infect Dis       Date:  2009-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.